severe

Vantage Foundation Donates HK$1 Million to Support Residents Affected by Hong Kong Fire

HONG KONG, Nov. 29, 2025 /PRNewswire/ -- Vantage Foundation has donated HK$1 million to support the emergency response and post-disaster reconstruction…

2 weeks ago

Over HK$100 Million Donated by Multiple Web3 FinTech Companies to Support Fire Victims

HONG KONG, Nov. 29, 2025 /PRNewswire/ -- On November 26, a severe Level-5 fire broke out at Hong Kong's Tai Po…

2 weeks ago

uniQure to Announce Third Quarter 2025 Financial Results

LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…

1 month ago

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

October 24, 2025 07:00 ET  | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…

2 months ago

Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza

Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together…

2 months ago

School Meals Save Lives and Strengthen Communities

On World Food Day, Education Cannot Wait calls for increased investment in school feeding programmes worldwide. NEW YORK, Oct. 16,…

2 months ago

36-Year-Old Man Given a Second Chance at Life With Advanced Heart Pump

INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old man with severe heart failure has been successfully…

2 months ago

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

3 months ago

EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30…

5 months ago

Shepherd Partners with Intel to Enhance its Endpoint Protection Suite with Hardware-based Ransomware Detection

Shepherd, a leading IoT and enterprise endpoint security and management vendor headquartered in India, has set out to integrate Intel…

5 months ago